Giulia Vanoni

PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions

Giuseppe Ercolano, Alejandra Gomez‐Cadena, Nina Dumauthioz et al. · Nature Communications · 2021 · 82 citations · Full text

Medicine, Oncology, Pharmacology +16

CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML

Bérengère Salomé, Alejandra Gomez‐Cadena, Romain Loyon et al. · Blood Advances · 2019 · 64 citations · Full text

Life Sciences, Hematology, Immunology +7

Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

Manuel Rodrigues, Giulia Vanoni, Pierre Loap et al. · Nature Communications · 2023 · 52 citations · Full text

Medicine, Immunology, Oncology +17

Immunosuppressive Mediators Impair Proinflammatory Innate Lymphoid Cell Function in Human Malignant Melanoma

Giuseppe Ercolano, Andrea Garcia-Garijo, Bérengère Salomé et al. · Cancer Immunology Research · 2020 · 33 citations

Life Sciences, Immunology, Oncology +17

Neural anticipation of virtual infection triggers an immune response

Sara Trabanelli, Michel Akselrod, Julia Fellrath et al. · Nature Neuroscience · 2025 · 23 citations · Full text

Life Sciences, Immunology, Neuroscience +17